In our illustrative case, all primary glioma patients with low ADAMTSL4 expression have better overall survival than those with high ADAMTSL4 expression (P < 0.0001, Figure 3D left; P = 0.00023, Figure 3D middle; P = 0.0036, Figure 3D right). The gene discussed is ADAMTSL4; the disease is central nervous system cancer.